Cargando…

Desensitization to liposomal amphotericin B after anaphylaxis in a patient with COVID-19-associated mucormycosis – A case with review of literature

Detalles Bibliográficos
Autores principales:	Swain, Satish, Ray, Animesh, Wig, Naveet, Trikha, Anjan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2022
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9249153/ https://www.ncbi.nlm.nih.gov/pubmed/35546469 http://dx.doi.org/10.4103/ijp.ijp_883_21

Ejemplares similares

Amphotericin-B-liposomal: Anaphylaxis: case report
Publicado: (2022)

Bronchoscopic instillation of liposomal amphotericin B in management of nonresponding endobronchial mucormycosis
por: Nattusamy, Loganathan, et al.
Publicado: (2017)

Outcomes of HFNC Use in COVID-19 Patients in Non-ICU Settings: A Single-center Experience
por: Aggarwal, Anivita, et al.
Publicado: (2022)

1554. Nebulized Liposomal Amphotericin B for Treatment of Murine Pulmonary Mucormycosis
por: Sandoval, Adilene, et al.
Publicado: (2019)

Sinonasal mucormycosis and liposomal amphotericin B: A quest for dose optimization
por: Kajal, Smile, et al.
Publicado: (2022)

Successful treatment of cutaneous mucormycosis disseminated from pulmonary mucormycosis with liposomal amphotericin B and posaconazole
por: Ding, Xiao-Lan, et al.
Publicado: (2020)

Successful Treatment of Disseminated Fusariosis with the Combination of Voriconazole and Liposomal Amphotericin B
por: Efe İris, Nur, et al.
Publicado: (2016)

Successful desensitization of pemetrexed-induced anaphylaxis in a patient with malignant mesothelioma
por: Youk, Jeonghwan, et al.
Publicado: (2017)

Combination treatment of liposomal amphotericin B and isavuconazole is synergistic in treating experimental mucormycosis
por: Gebremariam, Teclegiorgis, et al.
Publicado: (2021)

Successful Rapid Desensitization of a Pediatric Multiple Sclerosis Patient with Anaphylaxis to Ocrelizumab
por: Karaaslan, Hatice B. G., et al.
Publicado: (2022)

745. Combination Treatment of Liposomal Amphotericin B and Isavuconazole is Synergistic in Treating Experimental Mucormycosis
por: Gebremariam, Teclegiorgis, et al.
Publicado: (2020)

Lyme arthritis: A prospective study from India
por: Gupta, Nitin, et al.
Publicado: (2019)

Amphotericin-B liposomal /mycophenolic acid/tacrolimus: Mucormycosis and lack of efficacy: 2 case reports
Publicado: (2021)

Asystolic cardiac arrest following liposomal amphotericin B infusion: anaphylaxis or compliment activation-related pseudoallergy?
por: Drewett, George P., et al.
Publicado: (2021)

Liposomal amphotericin B—the present
por: Maertens, J, et al.
Publicado: (2022)

Liposomal amphotericin B—the past
por: Brüggemann, R J, et al.
Publicado: (2022)

Liposomal amphotericin B—the future
por: Hoenigl, M, et al.
Publicado: (2022)

Rhinocerebral mucormycosis treated with 32 gram liposomal amphotericin B and incomplete surgery: a case report
por: Çagatay, Atahan A, et al.
Publicado: (2001)

Combination of amphotericin B and caspofungin in the treatment of mucormycosis
por: Gargouri, Marwa, et al.
Publicado: (2019)

845. Clinical Outcomes in Patients Treated with High vs. Standard Dose Liposomal Amphotericin B for Invasive Mucormycosis
por: Valiante, Sarah, et al.
Publicado: (2023)

Liposomal Amphotericin B Treatment and the Leishmaniases
por: Berman, Jonathan
Publicado: (2019)

Amphotericin-B/amphotericin-B-liposomal: Lack of efficacy: 2 case reports
Publicado: (2022)

WCN23-0704 Liposomal amphotericin associated nephrotoxicity in patients with Mucormycosis: An epidemic in the midst of Pandemic
por: KISHAN, A., et al.
Publicado: (2023)

Liposomal Amphotericin B and Leishmaniasis: Dose and Response
por: Sundar, Shyam, et al.
Publicado: (2010)

Amphotericin-B-liposomal: No improvement: case report
Publicado: (2022)

Transcutaneous retrobulbar amphotericin-B (TRAMB) injection in orbital mucormycosis
por: Singh, Prabhakar, et al.
Publicado: (2022)

Successful treatment of rhinoorbital mucormycosis due to Rhizopus arrhizus with liposomal amphotericin B, posaconazole and surgical debridement in a child with neuroblastoma
por: Athanasiadou, Kleoniki I., et al.
Publicado: (2019)

Outcome of transcutaneous retrobulbar injection of liposomal amphotericin B in post-COVID-19 rhino-orbito-cerebral mucormycosis: Our experience
por: Ramamurthy, Lakshmi B, et al.
Publicado: (2022)

Levodropropizine-Induced Anaphylaxis: Case Series and Literature Review
por: Song, Jae-Won, et al.
Publicado: (2017)

Treatment of mucosal leishmaniasis with amphotericin B lipid complex (ABLC)
por: Tuon, Felipe Francisco, et al.
Publicado: (2018)

Nephrotoxicity of three formulations of amphotericin B: trial sequential analysis
por: Caputo, Rosaria, et al.
Publicado: (2020)

Acquiring Ventilators: Fighter Planes without High-octane Fuel and Pilots: Indian Perspective in COVID Era
por: Aggarwal, Richa, et al.
Publicado: (2020)

Is it Time to Go Back to Basics?
por: Chaturvedi, Apoorv, et al.
Publicado: (2021)

Risk factors for Coronavirus disease-associated mucormycosis
por: Arora, Umang, et al.
Publicado: (2022)

Successful Treatment of Mucormycosis Caused by Rhizopus arrhizus With Amphotericin B and Itraconazole
por: Cham, Chen Yi, et al.
Publicado: (2023)

Amphotericin B colloidal dispersion: an effective drug for the treatment of mucormycosis in China
por: Liu, Juntao, et al.
Publicado: (2023)

In vitro activities of amphotericin B deoxycholate and liposomal amphotericin B against 604 clinical yeast isolates
por: Montagna, Maria Teresa, et al.
Publicado: (2014)

Combination liposomal amphotericin B, posaconazole and oral amphotericin B for treatment of gastrointestinal Mucorales in an immunocompromised patient
por: Anderson, Anthony, et al.
Publicado: (2017)

Anaphylaxis after Idarucizumab Infusion
por: Nam, Ki-Woong, et al.
Publicado: (2017)

Liposomal amphotericin B as a treatment for human leishmaniasis
por: Balasegaram, Manica, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_i8pjqshvgted4gcs791eh2te35